AI and Drug Development: IP and data protection challenges

Artificial intelligence (AI) is not new to the life sciences industry but its use in drug development is rapidly growing, as life sciences companies increasingly recognize the benefits of...

Brexit - What Next?

Regulatory framework, data protection, intellectual property, legal environment - what you should not lose sight of? What impact has the potential Brexit for banks and insurance companies?...

Loading data